Skip to content
POM-V Prescription Required

Rispoval IBR-Marker Inactivated Suspension for Injection for Cattle

Active ingredient: Infectious bovine rhinotraceitis virus

Form

Injection

Species

Cattle

Manufacturer

Zoetis Belgium S.A.

VMD MA No.

60021/3050

What it's used for

The vaccination of pregnant cattle will prevent abortion associated with BoHV-1 infections as demonstrated during the second trimester of gestation upon ch...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Infectious bovine rhinotrace...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Rispoval IBR-Marker Inactivated Suspension for Injection for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

The vaccination of pregnant cattle will prevent abortion associated with BoHV-1
infections as demonstrated during the second trimester of gestation upon challenge
28 days after vaccination. Vaccinated cattle can be differentiated from field virus
infected animals due to the marker deletion, unless the cattle were previously
vaccinated with a conventional vaccine or infected with field virus.
Duration of immunity: 6 months.
Additional information on protection afforded by combined vaccination of
Rispoval IBR-Marker Vivum* with Rispoval IBR-Marker Inactivatum: for booster
immunisation after primary vaccination with Rispoval IBR-Marker Vivum* to reduce
the virus shedding and the clinical signs associated with BoHV-1 infection in cattle
and, in female cattle, to prevent abortions associated with BoHV-1 infection. This
vaccination of cattle will prevent abortion associated with BoHV-1 infections as
demonstrated during the third trimester of gestation upon challenge 86 days after the
booster vaccination.
Duration of immunity: 6 months after complete primary vaccination with Rispoval
IBR-Marker Vivum* followed by 12 months after annual booster with Rispoval IBR-
Marker Inactivatum.
In order to prevent abortion in female cattle that have received basic immunisation, a
single dose revaccination with Rispoval IBR-Marker Inactivatum is recommended to
be applied no later than by the start of the second trimester of each further
pregnancy.
* Where this veterinary medicinal product is authorised.
The vaccination scheme consists of basic immunisation and booster vaccinations.
Basic immunisation:
Cattle at 3 months of age or older at first vaccination
Two doses, each of 2 ml, 3-5 weeks apart.
Booster vaccinations:
Booster vaccinations of cattle having been administered the primary vaccination
scheme using Rispoval IBR-Marker Inactivatum:
One dose of 2 ml at 6 month intervals.
Booster Vaccinations of cattle having been administered the primary vaccination
scheme using Rispoval IBR-Marker Vivum*:
Cattle having been administered the primary vaccination scheme using Rispoval
IBR-Marker Vivum* (according to the product information for this veterinary medicinal
product) may be given booster vaccinations with Rispoval IBR-Marker Inactivatum.
These animals should be given a single dose booster vaccination with Rispoval IBR-
Marker Inactivatum 6 months after their initial vaccination course with Rispoval IBR-
Marker Vivum*. Thereafter, single dose booster vaccinations with Rispoval IBR-
Marker Inactivatum should be administered every 12 months.
If calves under the age of 3 months should be vaccinated the development of
immunity may be impaired by maternal antibodies. These calves should be
revaccinated when they are over 3 months of age.
It is recommended to vaccinate all cattle of a herd.
For female cattle for protection against abortion:
To prevent abortions associated with BoHV-1 female cattle require a primary course
of two subcutaneous doses of vaccine 3-5 weeks apart, or alternatively a primary
course of a single intramuscular dose of Rispoval IBR-Marker Vivum* followed 6
months later by a single dose booster using Rispoval IBR-Marker Inactivatum. In
order to cover the main abortion risk period, it is recommended that the second dose
of the primary course of two subcutaneous doses or the single dose booster using
Rispoval IBR-Marker Inactivatum is administered no later than by the start of the
second trimester of each pregnancy.
Method of administration:
Shake the vaccine well before use. Use only sterile needles and syringes for
administration. Avoid the introduction of contamination during use. The liquid
suspension is injected aseptically via the subcutaneous route.
Vaccination schemes summary:
From 2 weeks to 3 months of age
Rispoval IBR-Marker vaccine usedPrimary VaccinationRevaccination IntervalsFirst dose
(vaccine, route of
administration)
Second dose
(vaccine, route
of
administration)
Interval to next
booster
vaccination
(vaccine, route of
administration)
All subsequent
booster
vaccinations
(vaccine, route of
administration)
2 weeks (Vivum*,
intranasal)
3 months
(Vivum*,
intramuscular)
6 months (Vivum*,
intramuscular)
6 months (Vivum*,
intramuscular)
2 weeks (Vivum*,
intranasal)
3 months
(Vivum*,
intramuscular)
6 months
(Inactivatum,
subcutaneous)
12 months
(Inactivatum,
subcutaneous)
From 3 months of ageRispoval IBR-Marker vaccine usedRevaccination IntervalsPrimary Vaccination
(number of doses, route of
administration)
Interval to first
booster vaccination
(vaccine, route of
administration)
All subsequent
booster vaccinations
(vaccine, route of
administration)
Vivum* (one dose, intramuscular
or intranasal)
6 months (Vivum*,
intramuscular)
6 months (Vivum*,
intramuscular)
Vivum* (one dose,
intramuscular)
6 months
(Inactivatum,
subcutaneous)
12 months
(Inactivatum,
subcutaneous)
Inactivatum (two doses,
subcutaneous, with 3-5 week
interval)
6 months
(Inactivatum,
subcutaneous)
6 months (Inactivatum,
subcutaneous)
For female cattle for protection against abortion
Rispoval IBR-Marker vaccine usedPrimary Vaccination
(number of doses, route
of administration)
recommended to be
applied no later than by
the start of second
trimester of pregnancy
Revaccination
Vivum* (two doses,
intramuscular, with 3-5 weeks
interval)
Vivum* (one dose, intramuscular)
followed by Inactivatum (one
dose, subcutaneous), with 6
months interval
Inactivatum (two doses,
subcutaneous, with 3-5 week
interval)
Inactivatum (one dose, subcutaneous)
recommended to be applied no later than by
the start of the second trimester of each
pregnancy
For vaccination in known high BoHV-1 infection pressure
Rispoval IBR-Marker vaccine usedRevaccination IntervalsPrimary Vaccination
(number of doses,
route of
administration)
Interval to first
booster
vaccination
(vaccine, route of
administration)
All subsequent
booster
vaccinations
(vaccine, route of
administration)
Vivum* (one dose,
intranasal), followed by
Vivum* (one dose,
6 months (Vivum*,
intramuscular, OR
Inactivatum,
subcutaneous)
6 months (Vivum*,
intramuscular) OR 12
months (Inactivatum,
subcutaneous)
intramuscular) with 3-5
weeks interval
* Where this veterinary medicinal product is authorised.
None.
Cattle:
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Injection site swelling
,
Allergic reaction
1
Transient subcutaneous, up to 5 cm, which subsides within 14 days.
Vaccinated animals should be observed for approximately 30 minutes following
immunisation. If such reactions occur, antiallergics should be administered.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder <or its local representative> or the
national competent authority via the national reporting system. See the package
leaflet for respective contact details.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Immunosuppressive substances, i.e. corticosteroids or Bovine Virus Diarrhoea
modified live vaccines, should be avoided in a period of 7 days prior to and after
vaccination as this may impair the development of the immunity.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.
Store in a refrigerator (2 °C – 8 °C).
Do not freeze.
Protect from light.
Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.